Kronos Advanced Technologies Inc. Completes Acquisition of Zyppah Inc., Establishes New Subsidiary to Advance Sleep Apnea Solutions and Drive Digital Health Innovation
Plans Rights Offering for Shareholders
LOS ANGELES, CA / ACCESS Newswire / January 5, 2026 /Kronos Advanced Technologies Inc. (OTC:KNOS), a leader in innovative health and wellness technologies, today announced the successful completion of its acquisition of Zyppah Inc., a prominent provider of patented, FDA cleared, anti-snoring devices and sleep apnea solutions based in Nevada. In support of this strategic move, Kronos has formed a wholly owned subsidiary, Zyppah Inc., in State of Colorado. This acquisition positions Kronos to expand into the rapidly growing sleep apnea market, integrating Zyppah 's proven products with KronosMD 's advanced digital health technologies to deliver enhanced, personalized solutions that could boost shareholder value.
The transaction combines Zyppah® established anti-snoring mouthpieces,which have generated over $55 million in cumulative sales since inception, with KronosMD 's upcoming remote ultrasound imaging and monitoring innovations. Upon completion of KronosMD 's product development, this synergy will enable the production of custom-fitted Zyppah® anti-snoring appliances, offering superior efficacy, user satisfaction, and revenue opportunities in the sleep apnea solutions sector.
Zyppah 's patented "Seatbelt for the Tongue" technology uniquely integrates jaw positioning and tongue stabilization, achieving a 91% clinical success rate-the only such design on the market-and has assisted more than 500,000 individuals worldwide. Its FDA-cleared offerings, including the ZYPPAH® Edge and Beauty Sleep models, provide non-surgical, over-the-counter relief for snoring and mild sleep apnea.
KronosMD 's SWAVE™ platform leverages AI-driven 3D ultrasound for radiation-free, remote dental imaging, producing precise models for customized devices.This integration will allow Kronos to offer advanced, tailored sleep apnea treatments, such as optimized Zyppah® mouth guards with exact-fit scans for improved comfort and outcomes. Furthermore, it paves the way for hybrid products merging physical appliances with digital health tools, like mobile, AI powered apps for sleep tracking and device performance monitoring, aligning with trends in personalized medicine and appealing to investors focused on digital health growth.
"This acquisition represents a transformative milestone for Kronos, blending our ultrasound remote imaging technology patent with Zyppah 's market-leading expertise in anti-snoring devices and sleep apnea solutions," stated Greg Rubin, CEO of Kronos Advanced Technologies Inc. "We are poised to accelerate innovation, capture greater market share in digital health, and provide non-invasive options to millions affected by sleep disorders, ultimately driving potential shareholder gains."
Dr. Jonathan Greenburg, Founder and CEO of Zyppah Inc., added, "We are thrilled to join the Kronos family, uniting our snoring solutions proficiency with their cutting-edge technologies to pioneer more effective treatments for sleep disorders globally."
In connection with the acquisition, Kronos Advanced Technologies Inc. (OTC: KNOS) is pleased to notify its shareholders and those of the acquired Zyppah Inc. (Nevada) of an anticipated rights offering in the near term. This non-transferable offering will grant eligible Kronos and former Zyppah shareholders the opportunity to acquire additional Kronos common stock shares at a discounted price below market value, enabling them to preserve or expand their ownership in the merged entity. The proceeds will fund integration,product advancement, and growth in sleep apnea solutions and digital health markets, pending final terms, regulatory clearances, and adherence to securities regulations. Specifics, such as subscription pricing, ratio, and record date, will be revealed in the official announcement; shareholders should consult the prospectus for complete details. This initiative reflects Kronos ' dedication to enhancing shareholder value, although results may differ due to market dynamics and factors detailed in SEC filings.
The sleep apnea device market is experiencing robust expansion, fueled by heightened awareness of sleep health and technological advancements.Industry projections indicate the global market could reach $13.18 billion by 2034, growing at over 7% annually from 2025, propelled by innovative diagnostics and therapies. In the digital health arena, AI, wearables, and remote monitoring are revolutionizing care, with sleep tech expanding at 18.3%yearly through 2033 as consumers demand convenient, home-based snoring and sleep apnea solutions amid increasing obesity and aging demographics. Collaborations and data-driven adherence strategies are also key, presenting strong investment potential in this space.
This strategic acquisition underscores Kronos ' evolution from air purification origins toward high-growth sectors like sleep apnea solutions and digital health platforms, aiming for increased market penetration and benefits for OTC Markets participants.
About Zyppah Inc.
Zyppah Inc., founded by Dr. Jonathan Greenburg-a renowned bio-engineer, celebrity sleep doctor, and expert in snoring and sleep apnea treatments-specializes in innovative anti-snoring devices and sleep apnea solutions designed to address the root causes of sleep disruptions. The company offers a range of FDA-cleared, patented products featuring its unique "Seat belt for the Tongue" technology, which combines tongue stabilization and mandibular advancement for a dual-action approach to prevent airway blockage. Key offerings include the ZYPPAH® Pro mouthpiece, Special Edition Beauty Sleep, mouth tape supplies, nasal strips, and double packs, all engineered for custom comfort through a simple boil-and-bite fitting process.
Backed by a published, peer-reviewed clinical study involving 570 participants, Zyppah 's solutions boast a 91% success rate in stopping snoring, while maintaining 100% safety.
Having helped over 500,000 individuals worldwide achieve better sleep without surgery, Zyppah 's clinically proven, doctor-trusted products stand out in the market, with notable appearances on The Dr. Oz Show and prior endorsement from NBA legend Shaquille O 'Neal as global brand ambassador, supported by industry leaders and a commitment to causes like breast cancer awareness. Learn more at www.zyppah.com.
About Kronos Advanced Technologies Inc. Kronos Advanced Technologies Inc. (OTC: KNOS) develops and markets innovative health and wellness products, including air purification systems and digital health solutions through its KronosMD subsidiary. For more information, visit www.kronosati.co.
Founded in 2002 and initially funded by the U.S. military, Kronos Advanced Technologies Inc. (OTC: KNOS) has evolved into a diversified technology company with a strong focus on air purification, digital health innovations, and next-generation energy solutions. The company has pioneered electrostatic air movement and filtration technology, achieving a breakthrough in high-efficiency, filter-less air purification and securing FDA 510(k) clearance for its medical-grade air purifiers.
Over the years, Kronos has expanded into new markets through strategic innovation and IP and technology acquisitions, leading to the formation of two high-impact subsidiaries: KronosMD Inc. and Zyppah Inc. (Colorado)
KronosMD Inc. - Transforming Digital Dental Health with 3D Ultrasound Imaging
KronosMD Inc. is an industry disruptor in dental diagnostics and digital health, pioneering the S-WAVE™ ultrasound 3D imaging technology-the first point-of-care, remote 3D dental ultrasound platform powered by AI. This patented innovation provides real-time, radiation-free imaging, enabling dentists to detect cracks, cavities, and faulty restorations more accurately than ever before.
The S-WAVE™ system features a proprietary intraoral 3D ultrasound sensor that seamlessly integrates with mobile devices, allowing patients and dentists to perform remote digital impressions, making it a game-changer for Invisalign® clear aligners, implant planning, and orthodontic applications.
KronosMD is redefining modern dentistry by integrating AI-driven diagnostics, SaaS-based imaging solutions, and cloud connectivity. The company 's robust IP portfolio covers multiple patents related to digital dental imaging, positioning KronosMD at the forefront of AI-powered dental healthcare.
Shaping the Future of Technology
Kronos Advanced Technologies Inc. continues to drive innovation in air purification, digital health, and energy storage, leading with proprietary IP, breakthrough research, and scalable technology solutions. Through KronosMD Inc. and Zyppah Inc., the company is reshaping industries, improving global health, safety, and sustainability with cutting-edge solutions.
Company offices are located in Parkersburg, West Virginia.
Shopping portal: www.KronosAIR.com
Follow KNOS on X.com : https://X.com/kronosair
Follow KNOS on Facebook: https://www.facebook.com/kronosair
Follow KNOS on Instagram: https://www.instagram.com/kronos_air
Follow KNOS on YouTube: https://www.youtube.com/@KronosAdvancedTechnologies
Follow KNOS on Reddit: https://www.reddit.com/user/Kronos_ATI
Follow KNOS on LinkedIn: https://www.linkedin.com/company/kronos-advanced-technologies-inc
Contact us via info@kronosati.co
Social Media Disclaimer and Forward-Looking Statements
Kronos Advanced Technologies investors and others should note that we announce material information to the public about the Company through various means, including our website (www.KronosAIR.com), press releases, OTC markets filings, public conference calls, and via our corporate social media accounts listed above. We encourage our investors and others to monitor and review the information we make public in these locations, as such information could be deemed material. Please note that this list may be updated from time to time. Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the SEC and/or OTC Markets at OTCMarkets.com. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company 's ability to raise capital on acceptable terms, if at all, the Company 's successful development of its products and the integration into its existing products and the commercial acceptance of the Company 's products. The forward-looking statements included in this press release represent the Company 's views as of the date of this press release, and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company 's views as of any date subsequent to the date of the press release.
Tel: (716) OTC-KNOS (716-682-5667) for SMS text messages only
SOURCE: Kronos Advanced Technologies Inc.
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.
